Ms. Cheryl Dianne Planert, LMFT Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 530 First St., Se, Beach, ND 58621 Phone: 701-872-2667 |
News Archive
There has been a lot of debate regarding the effectiveness of breast cancer screening in the UK. It is being reviewed yet again. The NHS says screening saves lives, but other researchers have argued that it may cause more harm than good.
What has been revealed is that the systems set up during an industrial era to provide health care, retirement income and support during economic downturns are inadequate for and ill-suited to our post-industrial, globalized economy. ...one can imagine a system in which all workers and nonworkers are required to buy insurance from the government-regulated exchanges being set up in each region or state under the Obama health-care reform plan.
Boehringer Ingelheim announced the submission of a Marketing Authorisation Application to the European Medicines Agency for the approval of its oral triple angiokinase inhibitor nintedanib, in combination with docetaxel, for the treatment of patients with locally advanced, metastatic or recurrent non-small cell lung cancer (NSCLC) of adenocarcinoma tumour histology after first line chemotherapy.
BBI Solutions has announced the launch of a range of antibodies for the biomarker Galectin-3. The antibodies complement BBI's Galectin-3 antigen, which was also launched earlier this year.
› Verified 2 days ago